KAT6A directly binds to and acetylates SMAD3 at K20 and K117, which promotes SMAD3 association with oncogenic chromatin modifier TRIM24 and disrupts its interaction with tumor suppressor TRIM33. The gene discussed is SMAD3; the disease is neoplasm.